KBY5015 Anticancer Drug Discovery |
|
|
|
|
|
|
|
|
0 |
0.00 |
KBY5015 Anticancer Drug Discovery |
|
|
|
|
|
|
|
|
|
|
KBY5015 Anticancer Drug Discovery |
|
|
|
|
|
|
|
|
|
|
KBY5005 Cell Culture Techniques |
3 |
1 |
1 |
2 |
|
|
|
3 |
10 |
41.67 |
KBY5005 Cell Culture Techniques |
O |
ED |
ED |
D |
|
|
|
O |
|
|
KBY5005 Cell Culture Techniques |
|
|
|
|
|
|
|
|
|
|
KBY5013 Current Advancements in Cancer Research |
|
|
|
|
|
|
|
|
0 |
0.00 |
KBY5013 Current Advancements in Cancer Research |
|
|
|
|
|
|
|
|
|
|
KBY5013 Current Advancements in Cancer Research |
|
|
|
|
|
|
|
|
|
|
KBY5009 Molecular Toxicology |
3 |
1 |
2 |
|
|
3 |
|
1 |
10 |
41.67 |
KBY5009 Molecular Toxicology |
O |
ED |
D |
|
|
O |
|
ED |
|
|
KBY5009 Molecular Toxicology |
|
|
|
|
|
|
|
|
|
|
KBY5014 Cancer Cell Metabolism |
3 |
2 |
|
3 |
|
2 |
1 |
|
11 |
45.83 |
KBY5014 Cancer Cell Metabolism |
O |
D |
|
O |
|
D |
ED |
|
|
|
KBY5014 Cancer Cell Metabolism |
|
|
|
|
|
|
|
|
|
|
KBY5011 Cancer Bioinformatics |
2 |
3 |
3 |
2 |
3 |
2 |
2 |
1 |
18 |
75.00 |
KBY5011 Cancer Bioinformatics |
D |
O |
O |
D |
O |
D |
D |
ED |
|
|
KBY5011 Cancer Bioinformatics |
|
|
|
|
|
|
|
|
|
|
KBY5012 Tumor Heterogeneity and Drug Resistance |
3 |
3 |
2 |
3 |
1 |
2 |
|
|
14 |
58.33 |
KBY5012 Tumor Heterogeneity and Drug Resistance |
O |
O |
D |
O |
ED |
D |
|
|
|
|
KBY5012 Tumor Heterogeneity and Drug Resistance |
|
|
|
|
|
|
|
|
|
|